Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial-Reference-Cited by-同舟云学术

Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial

Published:2006-03-24 Issue:7 Volume:132 Page:458-465
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Sun Hui-Chuan,Tang Zhao-You,Wang Lu,Qin Lun-Xiu,Ma Zeng-Chen,Ye Qin-Hai,Zhang Bo-Heng,Qian Yong-Bin,Wu Zhi-Quan,Fan Jia,Zhou Xin-Da,Zhou Jian,Qiu Shuang-Jian,Shen Yue-Fang

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-006-0091-y.pdf

Reference38 articles.

1. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 214:114–117

2. Chung YH, Song IH, Song BC, Lee GC, Koh MS, Yoon HK, Lee YS, Sung KB, Suh DJ (2000) Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 88:1986–1991

3. Dupont WD, Plummer WD Jr (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11:116–128

4. van der Eijk AA, Niesters HG, Hansen BE, Heijtink RA, Janssen HL, Schalm SW, de Man RA (2006) Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha. J Viral Hepat 13:96–103

5. Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J (2000) Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 191:381–388

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions;Journal of Clinical and Translational Hepatology;2024-04-24

2. Interferon-α stimulates DExH-box helicase 58 to prevent hepatocyte ferroptosis;Military Medical Research;2024-04-15

3. Interferon therapy improves survival in patients with hepatitis B virus-related hepatocellular carcinoma after curative surgery: a meta-analysis;Hepatology International;2024-01-02

4. Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection;BMC Gastroenterology;2023-09-20

5. Adjuvant Lenvatinib in Combination with Transarterial Chemoembolization for Hepatocellular Carcinoma Patients with High-Risk of Postoperative Recurrence: A Prospective Cohort Study;2023-07-18